Medicare Reimbursements and Shortages of Sterile Injectable Pharmaceuticals
This paper investigates the rise in shortages of sterile injectable pharmaceutical drugs in the US. I examine a policy change in 2005 that differentially reduced Medicare Part B payments for pharmaceuticals. Drugs whose payments dropped more due to the policy change have had greater increases in shortages. I interpret these results using a model of entry and capacity choice with supply uncertainty. I conclude that Medicare's generous payments before the policy change provided manufacturers with incentives to invest in capacity or induced entry. The effect on total welfare of lowering payments is theoretically ambiguous.
|Date of creation:||Apr 2012|
|Date of revision:|
|Note:||HC HE IO|
|Contact details of provider:|| Postal: National Bureau of Economic Research, 1050 Massachusetts Avenue Cambridge, MA 02138, U.S.A.|
Web page: http://www.nber.org
More information through EDIRC
Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.:
- Ernst R. Berndt, 2002. "Pharmaceuticals in U.S. Health Care: Determinants of Quantity and Price," Journal of Economic Perspectives, American Economic Association, vol. 16(4), pages 45-66, Fall.
- Jeffrey Clemens & Joshua D. Gottlieb, 2014.
"Do Physicians' Financial Incentives Affect Medical Treatment and Patient Health?,"
American Economic Review,
American Economic Association, vol. 104(4), pages 1320-49, April.
- Jeffrey Clemens & Joshua D. Gottlieb, 2012. "Do Physicians' Financial Incentives Affect Medical Treatment and Patient Health?," Discussion Papers 11-017, Stanford Institute for Economic Policy Research.
- James D. Dana, 2000.
"Competition in Price and Availability when Availability is Unobservable,"
Econometric Society World Congress 2000 Contributed Papers
1450, Econometric Society.
- Dana, James D, Jr, 2001. "Competition in Price and Availability When Availability is Unobservable," RAND Journal of Economics, The RAND Corporation, vol. 32(3), pages 497-513, Autumn.
- Amy Finkelstein, 2004. "Static and Dynamic Effects of Health Policy: Evidence from the Vaccine Industry," The Quarterly Journal of Economics, Oxford University Press, vol. 119(2), pages 527-564.
- Crawford, Gregory S & Yurukoglu, Ali, 2011.
"The Welfare Effects of Bundling in Multichannel Television Markets,"
CEPR Discussion Papers
8370, C.E.P.R. Discussion Papers.
- Gregory S. Crawford & Ali Yurukoglu, 2012. "The Welfare Effects of Bundling in Multichannel Television Markets," American Economic Review, American Economic Association, vol. 102(2), pages 643-85, April.
- Carlton, Dennis W, 1978.
"Market Behavior with Demand Uncertainty and Price Inflexibility,"
American Economic Review,
American Economic Association, vol. 68(4), pages 571-87, September.
- D. W. Carlton, 1976. "Market Behavior With Demand Uncertainty and Price Inflexibility," Working papers 179, Massachusetts Institute of Technology (MIT), Department of Economics.
When requesting a correction, please mention this item's handle: RePEc:nbr:nberwo:17987. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: ()
If references are entirely missing, you can add them using this form.